Cosmos Health announced that the company has regained compliance with Listing Rule 5250(c)(1), in connection with the filing of its 2023 Annual Report on Form 10-K and its financial results for the first quarter ended March 31, 2024, on Form 10-Q. Based on the August 5 and August 19, 2024, filings of the company’s Form 10-K for the year ended December 31, 2023, and Form 10-Q for the period ended March 31, 2024, Nasdaq has determined that the company complies with the Filing Rule. Accordingly, this matter is now closed.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on COSM:
- Cosmos’ Cana completes facility upgrades, secures manufacturing agreement
- Cosmos Health reports Q1 EPS (11c) vs. (4c) last year
- Cosmos Health reports FY23 EPS ($2.15) vs. ($33.16) last year
- Cosmos Health’s Cana completes Phase 1 of production capacity expansion
- Cosmos Health announces contract manufacturing agreement with Humacology
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue